This brand name is authorized in Nigeria.
The drug ETHIZOLE contains one active pharmaceutical ingredient (API):
1
|
UNII
8VZV102JFY - FLUCONAZOLE
|
Fluconazole is a triazole antifungal agent. Its primary mode of action is the inhibition of fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis. |
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
A4-100476 | Capsule | ETHIZOLE 150MG CAPSULE CAP 150 mg 10X10 Tabs | 137 NF-PP-242631 ETHIZOLE 150MG CAPSULE FLUCONAZOLE 150MG CAPS fluconazole 150mg, EXCIPIENTS Capsules: Croscarmellose Sodium, Lactose, Magnesium Stearate, Colloidal Anhydrous Silica, Hard Empty Gelatin Capsules Drugs Imported Products 10X10 Tabs POM 2/9/2023 SK MEDICINES LIMITED, KOFO ABAYOMI STREET, VICTORIA ISLAND LAGOS MEDREICH LIMITED UNIT 1, 12TH , MILE , OLD MADRAS ROAD.VIRGONAGAR,BANGALORE . 560049 | 25/05/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
J02AC01 | Fluconazole | J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AC Triazole and tetrazole derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | A4-100476 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.